QS Investors’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-64,956
| Closed | -$1.08M | – | 2034 |
|
|
2017
Q3 | $1.08M | Sell |
64,956
-3,101
| -5% | -$50.4K | 0.01% | 791 |
|
|
2017
Q2 | $1.22M | Hold |
68,057
| – | – | 0.01% | 725 |
|
|
2017
Q1 | $1.36M | Sell |
68,057
-37,555
| -36% | -$875K | 0.01% | 708 |
|
|
2016
Q4 | $2.65M | Sell |
105,612
-11,196
| -10% | -$264K | 0.02% | 540 |
|
|
2016
Q3 | $2.73M | Hold |
116,808
| – | – | 0.02% | 573 |
|
|
2016
Q2 | $2.33M | Sell |
116,808
-51,600
| -31% | -$963K | 0.02% | 610 |
|
|
2016
Q1 | $2.85M | Buy |
168,408
+3,422
| +2% | +$70.1K | 0.03% | 556 |
|
|
2015
Q4 | $3.66M | Buy |
164,986
+132,411
| +406% | +$2.76M | 0.04% | 493 |
|
|
2015
Q3 | $553K | Hold |
32,575
| – | – | 0.01% | 871 |
|
|
2015
Q2 | $448K | Buy |
32,575
+75
| +0.2% | +$997 | 0.01% | 894 |
|
|
2015
Q1 | $445K | Buy |
+32,500
| New | +$375K | 0.01% | 900 |
|
|
2014
Q4 | – | Sell |
-22,500
| Closed | -$281K | – | 1398 |
|
|
2014
Q3 | $281K | Sell |
22,500
-5,900
| -21% | -$82.3K | 0.01% | 518 |
|
|
2014
Q2 | $389K | Buy |
+28,400
| New | +$371K | 0.01% | 498 |
|
|
2013
Q3 | – | Sell |
-55,300
| Closed | -$497K | – | 694 |
|
|
2013
Q2 | $497K | Buy |
+55,300
| New | +$557K | 0.02% | 523 |
|
QS Investors's OME Position: Q4 2017 in Review
QS Investors sold out of Omega Protein (OME) in Q4 2017, closing a stake of 64,956 shares — an estimated $1.08M sold.
QS Investors first reported a position in OME in Q2 2013 and held it in 14 quarters. The position peaked at $3.66M in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- QS Investors reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- QS Investors sold 64,956 Omega Protein shares in Q4 2017, an estimated $1.08M.
- QS Investors first reported a position in Omega Protein in Q2 2013 and held it in 14 quarters.
- QS Investors's Omega Protein position peaked at $3.66M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on QS Investors's 13F filing for Q4 2017, filed 14 Feb 2018.